Delivery Order SPE2DB20D1051-SPE2DB25FD9AY
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,401.39 by the Defense Logistics Agency (DLA) on August 8, 2025. The contract, designated as 4569035711, covers the supply of PREVNAR 20 vaccine in 0.5 milliliter syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,633.77 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,675.40 by the Defense Logistics Agency on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringe format. This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, with no set-aside designation applied. The award represents a competitively-bid delivery order executed under the company's existing contract vehicle with DLA, reflecting the agency's continued reliance on...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Prevnar 20 Syringe 0.5ML vaccines. This competitively awarded, firm fixed-price delivery order has a ceiling value of $73,941.30 and an ultimate completion date of July 23, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of PREVNAR 20 vaccine in syringe form (0.5mL). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,173.32 and is scheduled for completion by August 5, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract, valued at $98,026.20 with a firm fixed price structure, is scheduled for completion by August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, PA 19428. This is a competitively awarded,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $31.8K by the Defense Logistics Agency (DLA) on July 30, 2025, with a completion date of July 31, 2025. The contract involves the supply of PREVNAR 20 vaccine in syringe form (0.5mL), utilizing firm fixed price terms with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $19,605.24 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9AYDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency on August 13, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract utilizes firm fixed price terms with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The Prevnar 20 delivery order supports the Defense Health Agency and broader military healthcare logistics requirements by providing pneumococcal conjugate vaccine through DLA's established medical supply chain. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to fulfill competitive pharmaceutical procurement across therapeutic domains, with delivery orders ranging substantially in value. The company's performance under the DLA Troop Support Medical prime contract reflects its critical role in ensuring vaccine and pharmaceutical availability for Department of Defense healthcare systems, with the DLA Troop Support currently planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards and contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/13/25 |